Beraprost Sodium-impurities | Pharmaffiliates

beraprost sodium

Beraprost is also being studied for use in avoiding reperfusion injury. It is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension.. Reference standards of Beraprost Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Beraprost Sodium - API Standards 
    [catalogue_number] => PA 02 26000
    [category_ids] => ,69,71,78,70,82,
    [chemical_name] => 
    [weight] => 420.47
    [form] => C24H29NaO5
    [cas] => 88475-69-8
    [pslug] => 88475-69-8-beraprost-sodium-api-pa0226000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 26000

Beraprost Sodium - API Standards


  • Catalogue No.:PA 02 26000

  • CAS :

    88475-69-8

  • Molecular Formula : C24H29NaO5

  • Molecular Weight : 420.47